William Blair Issues Pessimistic Estimate for TARS Earnings
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share estimates for Tarsus Pharmaceuticals in a report released on Tuesday, February 25th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.82) for the quarter, down from […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share estimates for Tarsus Pharmaceuticals in a report released on Tuesday, February 25th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.82) for the quarter, down from […]
